NADAC acquisition cost data for OSCIMIN 0.125 MG ODT. This is a generic medication, typically more affordable than brand-name equivalents.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 68047025401 | $0.1618 | 2022-08-17 | Rx |
Generic: Hyoscyamine Sulfate | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $2.9K | 103 | 69 | $0.3469 |
| 2020 | $1.2K | 32 | 17 | $0.3486 |
| 2021 | $528.73 | 35 | 26 | $0.2732 |
| 2022 | $892.22 | 33 | 17 | $0.3240 |
| 2023 | $209.82 | 14 | 13 | $0.2463 |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.
Explore More Data Tools
For adjacent public-data tools, methodology notes, and network updates, visit DataPeek Facts.